Operational indicators for pulmonary tuberculosis diagnosis in people living with HIV before and after Xpert MTB/RIF implementation in the state of São Paulo, Brazil

被引:0
|
作者
de Faria, Mariana Gaspar Botelho Funari [1 ]
Andrade, Rubia Laine de Paula [1 ]
Leite, Karina Fonseca de Sousa [1 ]
Bonfim, Rafaele Oliveira [1 ]
Valenca, Ana Beatriz Marques [1 ]
Ramos, Antonio Carlos Vieira [1 ]
Berra, Thais Zamboni [1 ]
Arcencio, Ricardo Alexandre [1 ]
Rujula, Maria Josefa Peron [2 ]
Ballestero, Jaqueline Garcia de Almeida [1 ]
Chimara, Erica [3 ]
Ruffino Netto, Antonio [4 ]
Gomes, Dulce Maria de Oliveira [5 ]
Bollela, Valdes Roberto [4 ]
Monroe, Aline Aparecida [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Ribeirao Preto, SP, Brazil
[2] Sao Paulo State Dept Hlth, Ctr Epidemiol Surveillance, Sao Paulo, Brazil
[3] Govt State Sao Paulo, Adolfo Lutz Inst, Sao Paulo, Brazil
[4] Univ Sao Paulo, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil
[5] Univ Evora, Sch Sci & Technol, Evora, Alentejo, Portugal
来源
PLOS ONE | 2024年 / 19卷 / 06期
关键词
CHALLENGES; RISK; CARE;
D O I
10.1371/journal.pone.0305063
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tuberculosis (TB) in people living with HIV (PLHIV) is usually paucibacillary and the smear microscopy has limitations and may lead to high proportions of non-confirmed pulmonary tuberculosis (NC-PTB). Despite culture being the reference method, it usually takes 6 to 8 weeks to produce the results. This study aimed to analyze the effect of a rapid molecular test (Xpert) in the confirmatory rate of PTB among PLHIV, from 2010 to 2020, in S & atilde;o Paulo state, Brazil. This is an ecological study with time series analysis of the trend and the NC-PTB rates before and after Xpert implementation in 21 municipalities. The use of Xpert started and gradually increased after 2014, while the rate of NC-PTB in PLHIV decreased over this time, being more significant between late 2015 and mid-2017. The city of Ribeir & atilde;o Preto stands out for having the highest percentage (75.0%) of Xpert testing among PLHIV and for showing two reductions in the NC-PTB rate. The cities with low Xpert coverage had a slower and smaller decrease in the NC-PTB rate. Despite being available since 2014, a significant proportion of PLHIV suspected of PTB in the state of S & atilde;o Paulo did not have an Xpert ordered by the doctors. The implementation of Xpert reduced the NC-PTB rates with growing effect as the coverage increased in the municipality.
引用
收藏
页数:13
相关论文
共 27 条
  • [21] Utility of Xpert MTB/RIF Ultra and digital chest radiography for the diagnosis and treatment of TB in people living with HIV: a randomised controlled trial (XACT-TB)
    Mukoka, Madalo
    Twabi, Hussein H.
    Msefula, Chisomo
    Semphere, Robina
    Ndhlovu, Gabriel
    Lipenga, Trancizeo
    Sikwese, Tionge Daston
    Malisita, Kenneth
    Choko, Augustine
    Corbett, Elizabeth L.
    MacPherson, Peter
    Nliwasa, Marriott
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2023, 117 (01) : 28 - 37
  • [22] Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda
    Simon Walusimbi
    Brendan Kwesiga
    Rashmi Rodrigues
    Melles Haile
    Ayesha de Costa
    Lennart Bogg
    Achilles Katamba
    BMC Health Services Research, 16
  • [23] Cartridge-Based Automated Nucleic Acid Amplification Test (Xpert MTB/RIF) For The Diagnosis Of Pulmonary Tuberculosis In HIV-Infected And Uninfected Children: A Prospective Study
    Zar, H. J.
    Workman, L.
    Boehme, C.
    Eley, B.
    Nicol, M. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
    Tefera Agizew
    Violet Chihota
    Sambayawo Nyirenda
    Zegabriel Tedla
    Andrew F. Auld
    Unami Mathebula
    Anikie Mathoma
    Rosanna Boyd
    Anand Date
    Sherri L. Pals
    Phenyo Lekone
    Alyssa Finlay
    BMC Infectious Diseases, 19
  • [25] Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
    Agizew, Tefera
    Chihota, Violet
    Nyirenda, Sambayawo
    Tedla, Zegabriel
    Auld, Andrew F.
    Mathebula, Unami
    Mathoma, Anikie
    Boyd, Rosanna
    Date, Anand
    Pals, Sherri L.
    Lekone, Phenyo
    Finlay, Alyssa
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [26] Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting
    Nakiyingi, Lydia
    Bwanika, John Mark
    Ssengooba, Willy
    Mubiru, Frank
    Nakanjako, Damalie
    Joloba, Moses L.
    Mayanja-Kizza, Harriet
    Manabe, Yukari C.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [27] Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting
    Lydia Nakiyingi
    John Mark Bwanika
    Willy Ssengooba
    Frank Mubiru
    Damalie Nakanjako
    Moses L. Joloba
    Harriet Mayanja-Kizza
    Yukari C. Manabe
    BMC Infectious Diseases, 21